Initial safety and tumor control results from a "first-in-human" multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of locally advanced recurrent squamous cell carcinomas of the skin and head and neck - Popovtzer, A; Rosenfeld, E; Mizrachi, A (Int J Radiat Oncol Biol Phys, 2020)